Country Club Bank’s GSK GSK Stock Holding History

Country Club Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,629	Closed	-$363K	–	271
2022 Q2	$363K	Buy	6,629 +80	+1%	+$4.42K	0.03%	222
2022 Q1	$358K	Buy	+6,549	New	+$356K	0.03%	213

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Country Club Bank's GSK Position: Q3 2022 in Review

Country Club Bank sold out of GSK (GSK) in Q3 2022, closing a stake of 6,629 shares — an estimated $363K sold.

Country Club Bank first reported a position in GSK in Q1 2022 and held it in 2 quarters. The position peaked at $363K in Q2 2022. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Country Club Bank reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Country Club Bank sold 6,629 GSK shares in Q3 2022, an estimated $363K.
Country Club Bank first reported a position in GSK in Q1 2022 and held it in 2 quarters.
Country Club Bank's GSK position peaked at $363K in Q2 2022.
743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Country Club Bank's 13F filing for Q3 2022, filed 31 Oct 2022.